The Next Step for Drones: Blood Delivery? There's Opportunity, But Regulatory Hurdles - Corporate Counsel

Linda Pissott Reig, shareholder in the firm's FDA & Biotechnology section, comments on the risks and considerations of drones transporting blood in Corporate Counsel's article "The Next Step for Drones: Blood Delivery? There's Opportunity, But Regulatory Hurdles."

As with traditional medical air transport, there are many risks, arguably more with drones, associated with not managing materials carefully and securely, said Linda Pissott Reig, shareholder at Buchanan Ingersoll & Rooney.

"Can you imagine if there were an instance where drones were crashing and materials were spilling and not able to be controlled?" she said. "You have to ask, ‘Are they truly protected and secure? Is our system robust enough to ensure that if there is some mishap they are.'"